![\"\"](\"https:\/\/www.cloudbyz.com\/resources\/wp-content\/uploads\/2020\/04\/CB_BlogImage_1.png\")
<\/p>\n
1. Ensuring patient safety is a top priority at their sites.\u00a0Sponsors can do this by:<\/b><\/p>\n
\u00a0 \u00a0 \u00a0a.<\/b>\u00a0working with site coordinators and vendors to make sure masks, gloves and other necessary protective equipment are being delivered in the right quantities;<\/p>\n
\u00a0 \u00a0 \u00a0b.<\/b>\u00a0identifying and prioritizing sites that are conducting COVID-19 trials to expedite shipping to ensure on-time delivery;<\/p>\n
\u00a0 \u00a0 \u00a0c.<\/b>\u00a0conducting regular check-ins with site coordinators and offering resources to ensure patient safety is a top priority and not being compromised;<\/p>\n
\u00a0 \u00a0 \u00a0d.<\/b>\u00a0providing transportation and housing financial assistance to sites to ensure safe patient travel and accommodation.<\/p>\n
![\"\"](\"https:\/\/www.cloudbyz.com\/resources\/wp-content\/uploads\/2020\/04\/CB_BlogImage_2.png\")
<\/p>\n
2.\u00a0Collaborating and engaging with investigators.\u00a0Sponsors can do this by:<\/b><\/p>\n
a.<\/b>\u00a0considering holding off on trials where enrollment is challenging;<\/p>\n
b.<\/b>\u00a0speeding up protocol amendment submission;<\/p>\n
c.<\/b>\u00a0collaborating with software vendors and investigators to implement technology that can reduce administrative costs;<\/p>\n
d.<\/b>\u00a0creating a COVID-19 management and tracking system for every site;<\/p>\n
e.<\/b>\u00a0bridging the gap between regulatory agencies and sites by adhering to timely and efficient communication;<\/p>\n
f.<\/b>\u00a0offering flexible payment plans;<\/p>\n
g.<\/b>\u00a0and donating technological equipment like iPads, laptops, and other communicative devices.<\/p>\n
![\"\"](\"https:\/\/www.cloudbyz.com\/resources\/wp-content\/uploads\/2020\/04\/CB_BlogImage_3.png\")
<\/p>\n
3.\u00a0Focusing on what is in their control.\u00a0Sponsors can do this by:<\/b><\/p>\n
a.<\/b>\u00a0bridging the gap between pharma sales reps and physicians to efficiently manage resources and productivity;<\/p>\n
b.<\/b>\u00a0dedicating a team to speed up compound discovery to lighten the post virus blow;<\/p>\n
c.<\/b>\u00a0taking necessary steps to minimize research and development disruptions;<\/p>\n
d.<\/b>\u00a0collaborating with other pharmaceutical and biotech companies to speed up vaccine development;<\/p>\n
e.<\/b>\u00a0focusing on serological or antibody testing to test virus immunity;<\/p>\n
f.<\/b>\u00a0and understanding major foreign supply chain disruptions and pivoting to alternatives for the interim.<\/p>\n
Conclusion<\/b><\/p>\n
In such an unprecedented time, pharmaceutical and biotech companies are under immense pressure to speed up the race to find a vaccination, enable research and test sites, and above all, ensure patient safety is at utmost priority. It\u2019s now more than ever, that brilliant ideas, thoughtful leadership, and an empathetic approach can bring us closer to the light at the end of the tunnel.<\/p>\n
Click\u00a0<\/i>here<\/i><\/a>\u00a0to learn more about what Cloudbyz CTMS can do for your organization or request a\u00a0<\/i>virtual demo<\/i><\/a>\u00a0today. For more information, please e-mail us at\u00a0<\/i>info@cloudbyz.com<\/i><\/a>.<\/i><\/p>\n